The Metabolic Syndrome: A Practical Guide to Origins and Treatment: Part II

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · see citing works

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · see citing works

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · see citing works

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979 · see citing works

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · see citing works

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

Writing Committee Members:, Pasternak, R. C., Smith, S. C., Bairey-Merz, C. N., Grundy, S. M., Cleeman, J. I., & Lenfant, C. (2002) · Circulation · doi:10.1161/01.cir.0000032466.44170.44 · Cited by 1,088 · see citing works

Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach

Bergman, R. N. (1989) · Diabetes · doi:10.2337/diab.38.12.1512 · Cited by 1,001 · see citing works

Clustering of metabolic factors and coronary heart disease

Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712 · see citing works

Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?

Haffner, S. M. (1990) · JAMA · doi:10.1001/jama.1990.03440210043030 · Cited by 668 · see citing works

B vitamins, homocysteine, and neurocognitive function in the elderly

Selhub, J., Bagley, L. C., Miller, J. W., & Rosenberg, I. H. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.614s · Cited by 462 · see citing works

Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus.

Haffner, S., Stern, M., Hazuda, H., Pugh, J. A., & Patterson, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150403 · Cited by 358 · see citing works

The Importance of Diagnosing the Polycystic Ovary Syndrome

Løbo, R. A., & Carmina, E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-12-200006200-00010 · Cited by 306 · see citing works

Sex Differences in the Effect of Diabetes Mellitus on Lipoprotein Triglyceride and Cholesterol Concentrations

Walden, C. E., Knopp, R. H., Wahl, P. W., Beach, K. W., & Strandness, E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410113111505 · Cited by 253 · see citing works

High-density lipoprotein, low-density lipoprotein and coronary artery disease

Wilson, P. W. F. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90562-f · Cited by 228 · see citing works

Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC)

Vega, G. L., Clark, L. T., Tang, A., Marcovina, S. M., Grundy, S. M., & Cohen, J. C. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34218-8 · Cited by 160 · see citing works

Blood Lipid Measurements

Cooper, G. R. (1992) · JAMA · doi:10.1001/jama.1992.03480120090039 · Cited by 141 · see citing works

A BREIF ORIGINAL CONTRIBUTION

Anderson, R. L., Hamman, R. F., Savage, P. J., Saad, M. F., Laws, A., Kades, W. W., Sands, R., & Cefalu, W. T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/142.7.724 · Cited by 138 · see citing works

Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels

Tai, E. S., Demissie, S., Cupples, L. A., Corella, D., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012302.11991.42 · Cited by 136 · see citing works

Antihypertensive Therapy and the Risk of Type 2 Diabetes Mellitus

Sowers, J. R., & Bakris, G. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421310 · Cited by 130 · see citing works

A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study

Gagné, S., Larson, M. G., Pimstone, S., et al. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550609.x · Cited by 121 · see citing works

Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study

Couture, P., Otvos, J. D., Cupples, L. A., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00281-6 · Cited by 55 · see citing works

The ALLHAT Lipid Lowering Trial—Less Is Less

Pasternak, R. C. (2002) · JAMA · doi:10.1001/jama.288.23.3042 · Cited by 54 · see citing works

Overweight and Obesity as Determinants of Cardiovascular Risk: The Framingham Experience

Wilson, P. W. F., D'Agostino, R. B., Sullivan, L., Parise, H., & Kannel, W. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1867 · Cited by 22 · see citing works

Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease∗∗The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or other Departments of the US Government.

Greiner, D. Z., Personius, B. E., & Andrews, T. C. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00828-5 · Cited by 13 · see citing works

The effects of errors in lipid measurement and assessment

Cooper, G. R., Myers, G. L., Kimberly, M. M., & Waymack, P. P. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0114-5 · Cited by 12 · see citing works

Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee

Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705 · see citing works

Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006

Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000238352.25222.5e · Cited by 345 · see citing works

The association between adolescent depression and dyslipidemia

Khalfan, A. F., Campisi, S. C., Lo, R. F., McCrindle, B. W., & Korczak, D. J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.017 · Cited by 37 · see citing works

Stratifying the patient at risk from coronary disease: New insights from the framingham heart study

Levy, D. A., Wilson, P. W. F., Anderson, K. M., & Castelli, W. P. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80050-x · Cited by 157 · see citing works

The changes of serum lipids and lipoproteins in patients with acute cerebral stroke

Demarin, V., Bošnjak-Pašić, M., Vargek-Solter, V., et al. (1999)

Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients

Culleton, B. F., & Wilson, P. W. F. (1999) · Seminars in Dialysis · doi:10.1046/j.1525-139x.1999.00002.x · Cited by 12 · see citing works

Contribution of Vascular Risk Factors to Dementia and Dementia Risk Prediction Varies Across Mid-to Later-Life: The Framingham Heart Study (P1-1.Virtual)

McGrath, E. R., Beiser, A., O’Donnell, A., Himali, J. J., Pase, M. P., Satizábal, C. L., & Seshadri, S. S. (2022) · Neurology · doi:10.1212/wnl.98.18_supplement.139

State of the art coronary heart disease risk estimations based on the Framingham heart study.

Reissigová, J., & Tomečková, M. (2005) · PubMed · Cited by 7 · see citing works